Latest News in the Life Sciences Industry
PR Newswire Association LLC.
Newel Health and Gerresheimer Launch Strategic Collaboration to Support Pharma Companies in the Era of Integrated Digital Therapies
27 May 2026
GlobeNewswire
Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management
27 May 2026
PR Newswire Association LLC.
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
27 May 2026
GlobeNewswire
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026
26 May 2026
GlobeNewswire
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
26 May 2026
PR Newswire Association LLC.
ABILITY Neurotech Receives IMDD Approval to Start Clinical Trial for Chronic Implantation of Brain-Computer Interface in ALS Patients
26 May 2026
GlobeNewswire
New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength
26 May 2026
GlobeNewswire
Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke
26 May 2026
GlobeNewswire
The hidden impact of veterinary care: new insights from a global survey of veterinarians
25 May 2026
GlobeNewswire
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
22 May 2026
GlobeNewswire
CHMP issues positive opinion for JASCAYD® (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU
22 May 2026
GlobeNewswire
Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class
22 May 2026
GlobeNewswire
Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1)
22 May 2026
GlobeNewswire
China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis
22 May 2026
PR Newswire Association LLC.
Implantica publishes Interim Report January - March 2026 (Q1)
22 May 2026
PR Newswire Association LLC.
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan
22 May 2026
GlobeNewswire
Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
21 May 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan